Mary T. Szela, CEO and President at TriSalus Life Sciences, Inc. (TLSI), bought 30,487 shares at $4.10 ($125K) on 2026-02-23, disclosed to the SEC on 2026-02-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| TLSI | SELL | 2026-03-20 | $79K | — | Filing → |
| TLSI | BUY | 2025-01-31 | $52K | — | Filing → |
| TLSI | BUY | 2025-01-29 | $50K | — | Filing → |